Cytek Biosciences, Inc. (CTKB)
$5.35+0.75%Close
BUYBULL · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $691M
- Beta
- 1.16
- P/E (TTM)
- -8.59
- Short % float
- 4.41%
- Days to cover
- 3.1
- SI change
- -0.5%
- 1W
- -0.56%
- 1M
- +10.77%
- vs SPY 1W
- -0.42%
- vs SPY 1M
- +8.26%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 10
- GROWTH
- 36
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-14.1%
REV YoY-
ROE-23.5%
EPS YoY-
ROA-18.0%
GROSS53
OP-22
NET-39
[VALUATION]
P/E TTM-8.59
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B2.15
P/FCF-
EV/EBITDA-23.70
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E8.22
ALTMAN Z-
CURR RATIO4.48
ND/EBITDA-
BETA1.16
Company news
FAQ
- What is LOPJLB’s current signal on CTKB?
- LOPJLB’s latest quantitative signal on Cytek Biosciences, Inc. (CTKB) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CTKB in?
- Cytek Biosciences, Inc. (CTKB) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Cytek Biosciences, Inc. (CTKB) do?
- Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differ…